As of 2025-11-01, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (7.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.38 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -626.7%.
The range of the Relative Valuation is (6.24) - (7.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 22.5x | 19.9x |
| Forward P/E multiples | 18.8x - 29.0x | 23.9x |
| Fair Price | (6.24) - (7.48) | (7.27) |
| Upside | -552.2% - -642.1% | -626.7% |
| Date | P/E |
| 2025-10-30 | -4.04 |
| 2025-10-29 | -4.01 |
| 2025-10-28 | -4.13 |
| 2025-10-27 | -4.19 |
| 2025-10-24 | -4.28 |
| 2025-10-23 | -4.22 |
| 2025-10-22 | -4.19 |
| 2025-10-21 | -4.34 |
| 2025-10-20 | -4.58 |
| 2025-10-17 | -4.28 |
| 2025-10-16 | -4.43 |
| 2025-10-15 | -4.61 |
| 2025-10-14 | -4.40 |
| 2025-10-13 | -4.34 |
| 2025-10-10 | -4.49 |
| 2025-10-09 | -4.94 |
| 2025-10-08 | -4.31 |
| 2025-10-07 | -4.58 |
| 2025-10-06 | -4.67 |
| 2025-10-03 | -4.25 |
| 2025-10-02 | -4.16 |
| 2025-10-01 | -4.25 |
| 2025-09-30 | -4.07 |
| 2025-09-29 | -4.19 |
| 2025-09-26 | -4.22 |
| 2025-09-25 | -4.04 |
| 2025-09-24 | -4.01 |
| 2025-09-23 | -3.65 |
| 2025-09-22 | -3.49 |
| 2025-09-19 | -3.59 |
| 2025-09-18 | -3.68 |
| 2025-09-17 | -3.28 |
| 2025-09-16 | -3.31 |
| 2025-09-15 | -3.37 |
| 2025-09-12 | -3.46 |
| 2025-09-11 | -3.34 |
| 2025-09-10 | -3.25 |
| 2025-09-09 | -3.40 |
| 2025-09-08 | -3.25 |
| 2025-09-05 | -3.28 |
| 2025-09-04 | -3.22 |
| 2025-09-03 | -3.25 |
| 2025-09-02 | -3.37 |
| 2025-08-29 | -3.31 |
| 2025-08-28 | -3.46 |
| 2025-08-27 | -3.40 |
| 2025-08-26 | -3.43 |
| 2025-08-25 | -3.40 |
| 2025-08-22 | -3.59 |
| 2025-08-21 | -3.52 |